olopatadine hydrochloride
- Product NDC
- 61314-271
- 11-digit product format
- 613140271
- Labeler code
- 61314
- Product ID
- 61314-271_ad459669-1be0-42b3-90a5-d806b38199e5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- olopatadine hydrochloride
- Dosage form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Labeler
- Sandoz Inc
- Application
- NDA020688
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2015-09-15
- Marketing end
- 2022-11-30
- Substance
- OLOPATADINE HYDROCHLORIDE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61314-271-05 | 61314027105 | 1 BOTTLE, PLASTIC in 1 CARTON (61314-271-05) > 5 mL in 1 BOTTLE, PLASTIC | 2015-09-15 | 2022-11-30 | No | No | Current |